Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Farmers Insurance
Baxter
Covington
Argus Health

Generated: May 23, 2019

DrugPatentWatch Database Preview

ENBREL Drug Profile

« Back to Dashboard

Pharmacology for ENBREL

US Patents for ENBREL

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial TACT IP, LLC (Highland Beach, FL) ➤ Try a Free Trial RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial Immunex Corporation (Seattle, WA) ➤ Try a Free Trial RX Orphan company
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial LegoChem Biosciences, Inc. (Daejeon, KR) ➤ Try a Free Trial RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial CARDIONOVUM Sp.z.o.o. (Warsaw, PL) ➤ Try a Free Trial RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial NeuClone Biologics Pty Ltd (Eveleigh, NSW, AU) ➤ Try a Free Trial RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial Coherus Biosciences, Inc. (Redwood City, CA) ➤ Try a Free Trial RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial SANOFI BIOTECHNOLOGY (Paris, FR) REGENERON PHARMACEUTICALS, INC. (Tarrytown, NY) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patents for ENBREL

Supplementary Protection Certificates for ENBREL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
PA2017038,C2041177 Lithuania ➤ Try a Free Trial PRODUCT NAME: SARILUMABAS; REGISTRATION NO/DATE: EU/1/17/1196 20170623
44/2010 Austria ➤ Try a Free Trial PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE: EU/1/10/618/001-004 20100526
LUC00050 Luxembourg ➤ Try a Free Trial PRODUCT NAME: SARILUMAB ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (KEVZARA); AUTHORISATION NUMBER AND DATE: EU/1/17/1196 20170627
10C0050 France ➤ Try a Free Trial PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE IN FRANCE: EU/1/10/618/001 DU 20100526; REGISTRATION NO/DATE AT EEC: EU/1/10/618/001-004 DU 26-05-
SZ 44/2010 Austria ➤ Try a Free Trial PRODUCT NAME: DENOSUMAB
C300008 Netherlands ➤ Try a Free Trial PRODUCT: ETANERCEPTUM
17C1057 France ➤ Try a Free Trial PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170627
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKesson
US Army
Argus Health
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.